Physician profile
David Tran
NPI 1366419590
$31,657.40
in general payments reported to CMS, 2019-2025
73 companies · $4,243 in 2025
The $4,243 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,991 · 2020: $3,200 · 2021: $4,762 · 2022: $4,573 · 2023: $5,701 · 2024: $5,186 · 2025: $4,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $12.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,118.31 |
| Education | $12.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $5,795.25 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $3,182.32 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $2,902.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $2,115.79 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,410.26 | 2019-2025 | |
| Allergan, INC. | $1,222.26 | 2019-2021 | |
| Amgen INC. | $1,171.71 | 2021-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,129.68 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Axsome Therapeutics, INC. | $1,036.72 | 2022-2025 | Auvelity, Sunosi, Symbravo |
| Bayer Healthcare Pharmaceuticals INC. | $927.75 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $875.68 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Kowa Pharmaceuticals America, INC. | $857.07 | 2019-2023 | Seglentis, Livalo |
| Lundbeck LLC | $724.83 | 2022-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $684.38 | 2022-2025 | Qelbree, Qelbree, Xyosted |
| Glaxosmithkline, LLC. | $523.55 | 2022-2025 | Trelegy Ellipta |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $520.21 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $514.91 | 2019-2025 | Keytruda, Belsomra, Verquvo |
| Sanofi-Aventis U.S. LLC | $458.09 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $365.99 | 2019-2025 | Rexulti, Nuedexta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $353.78 | 2022-2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $353.17 | 2021 | |
| Horizon Therapeutics Plc | $307.69 | 2019-2023 | Krystexxa |
| Ironwood Pharmaceuticals, INC | $301.14 | 2019-2023 | Linzess |
| Idorsia Pharmaceuticals US INC | $300.14 | 2022-2024 | Quviviq |
| Esperion Therapeutics, INC. | $298.89 | 2020-2023 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $270.14 | 2019-2023 | Trintellix |
| Antares Pharma, INC. | $225.76 | 2024-2025 | Xyosted |
| Harmony Biosciences LLC | $217.11 | 2023-2025 | Wakix |
| Sunovion Pharmaceuticals INC. | $193.21 | 2019-2020 | |
| Amarin Pharma, INC. | $192.40 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $155.70 | 2019-2021 | |
| Kyowa Kirin, INC. | $149.86 | 2020-2022 | |
| Noven Therapeutics, LLC | $140.47 | 2025 | Xelstrym |
| Upsher-Smith Laboratories LLC | $130.47 | 2020-2022 | |
| Tolmar, INC. | $116.36 | 2024-2025 | Jatenzo |
| Nevro Corp. | $113.49 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $100.96 | 2021-2022 | |
| Eisai INC. | $95.15 | 2020-2025 | |
| Biogen, INC. | $89.72 | 2020-2022 | |
| Janssen Biotech, INC. | $83.33 | 2021 | |
| Vertiflex, INC. | $78.12 | 2019 | |
| Nestle Healthcare Nutrition INC. | $71.54 | 2022-2023 | |
| Stryker Corporation | $68.57 | 2023-2025 | Variax, Clottriever Bold Catheter, Fixos |
| Abbott Laboratories | $53.64 | 2022-2025 | Freestyle Libre 3 |
| Corium, LLC | $47.87 | 2023 | Azstarys |
| Vertex Pharmaceuticals Incorporated | $43.02 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.88 | 2020-2024 | Eliquis |
| Assertio Therapeutics, INC. | $37.52 | 2019 | |
| Clarus Therapeutics INC. | $36.06 | 2021 | |
| Inspire Medical Systems, INC. | $35.85 | 2025 | Inspire |
| Tactile Systems Technology INC | $35.61 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Acerus Pharmaceuticals Corporation | $34.06 | 2022 | |
| Halozyme INC | $32.80 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $32.59 | 2022 | |
| Currax Pharmaceuticals LLC | $31.86 | 2021-2024 | Onzetra Xsail, Contrave |
| Tris Pharma INC | $29.36 | 2022 | |
| Jazz Pharmaceuticals INC. | $28.89 | 2020-2021 | |
| Bioxcel Therapeutics, INC. | $28.46 | 2023 | Igalmi |
| Intra-Sana Laboratories | $26.01 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Boston Scientific Corporation | $24.42 | 2025 | Watchman Flx |
| Alexion Pharmaceuticals, INC. | $24.19 | 2023 | |
| Dexcom, INC. | $23.80 | 2024 | Dexcom G6 Transmitter |
| Kerecis Limited | $23.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Shield Therapeutics INC | $19.50 | 2023 | Accrufer |
| Avanir Pharmaceuticals, INC. | $19.48 | 2022 | |
| Sumitomo Pharma America, INC. | $19.47 | 2023 | Gemtesa |
| Renalytix Ai, INC. | $16.36 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Advanced Respiratory, INC | $16.01 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.86 | 2022 | |
| Exact Sciences Corporation | $14.92 | 2023 | Cologuard Collection Kit |
| Promius Pharma LLC | $14.21 | 2019 | |
| Genentech USA, INC. | $13.09 | 2019 | |
| Acadia Pharmaceuticals INC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.